L1-79 (Yamo Pharmaceuticals)

N/A

Report date: 2022/11/14 19:17:56
NME

Base Information

Drug NameL1-79 (Yamo Pharmaceuticals)
Drug Alias NameL1-79
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine 3-hydroxylase inhibitors
TargetsTyrosine 3-hydroxylase
Therapy Area/IndicationsAutistic DisorderAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesYamo Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesYamo Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsAutistic DisorderAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A